I need help please to make the assumption and other table to solve them.
here is it.
ASSUME THAT THE WIKIYOPMENT DATA (FORECASTING WEEKLY DEMAND) IS INDEPENDENT OF THIS ANALYSIS Desain your stutions and who for making the long term forecast Pronde weraphs used in long term forecasting them to the right of your assumption and forcat values. You may add row if you need additional space end Pemand What is your estimated forecasted demand for invane and Primaxin for 2018? Provide the answer in units of BOLES Provide a table of forecasted demand for strategic planning purposes for and Primetin below #1 Pesum LOW Options Pesimit dhe 2019 20 2011 1022 ACTUAL GLOBAL DEMAND SALES Year Global Invanz Sales SUS MM Global Primaxin Sales SUS MM 2010 2011 362 406 610 515 2012 445 384 2013 426 335 2014 488 329 2015 569 2016 561 2017 602 2018 (through end of September 437 Assume that 4th quarter= average of 1st 3 quarters 313 297 280 212 84 85 86 Process & Demand Data 87 88 89 90 Single Process Line Data Average #of Average Activity Process Step Bottles Waiting Time (minutes) Prior to Activity Bottle Staging 168 12.1 Bottle 257 29.08 Tunnel 209 10.9 Sterilization Aseptic Fill 220 Lyophilization 289 13.2 (Freeze-drying) Bottle Capping! 188 91 92 2.1 93 94 0.5 95 96 97 98 Merck & Co., Inc. has developed and currently manufactures tweinyectable and Prima Facerpts from selected Merck Longsoring Primas and invent state "Global sales of land for the treatment of certain infection were 5602 in 2017, one of Noned with 2016, darily by higher sales in the Nether partially offset by lower demands well as higher demand in Brel Worldwide sales of vowe 6 milioni 2016 dece of compared with 2015. Soles performance 2016 United States, largely offset by a dece in Venezue. The potent that provided for printer 2017 and the company antes de sus future periods After patent protection ends for agence ducers will introduce we cost of the product the speed andre of gener entries will end ended the attractiveness of market entry by merk manufacturers, the required and checturing the product. While itti och sextremely difficult to manufacture due to processing complexity and the difficulty le conformance in making roads in Mesother letter Primasin ended in 2008 and generic version entered the global mar 2010 Merck lost patient protection for invang in the US in November 2017 Online 21, 2018 Aurobindo accedere Oversion here for the Aur generic vans in the US at the end of july 2018 Inweis an antibiotic of last resort meaning that it tay only interefter other behave fled the cadence of infections that were to more con de help offset inreds from generic Clinical researchers estimate annual growth in demand for antibiotics such an in the low single data for the foreseeable future due to Demand for at produced by Merck will be dependent in garton Merck's bity to come out wity Performance they to successfully treated winner conformance quality le, meeting manufacturing specifications is an order cualifierConforman ulit nous concern poor quality product reches the market risk and the firm may need to conduct a product recall Product recalls are typically damaging to the stick once in the short term and potentially to the firm's brand the long term become increasingly important as new antibiotics enter the market and due to expected competition from producers of trans Generic ng mature may have introducing new drugs in part because they lack experience with the process. Merck has an advantage over Aurobindo in this respect that because they have length routine process average, at $1.9555 per bottle angle dose of Polisport Global sales of narand Prime we provided below through the end of September 2015. A single down (bottle) is on aver $1,31556 per bottle dose of the bed on average, ut $850.70 per bottle you can assume that this pricing will remain contant over the period of the strategic plan and that geen competition is present worldwide oluly 2013 Aurobindo has a slight cost (price) advantage over Merck for Invant, and that Aurobindo has adequate capacity to wohl demand for Invan. A new strategic plan is required to 2011 dude forecasts of sales of both products Sterile Fillinishing Process Aseptic fishing manufacturing of stene pharmaceutical products performed in a process that is de teren injectable product manner which we that the other it enters the packaging and remains contaminant-free over the life of the product the process is detonin houders/veer About 5 days of production per part failures. Primon and rare produced to the same facility, 9 days of production will be lost to change reacher An $W Calibri 14 -AX Mega - $ 96 9N Condition format Call Format We Style Shes a A- Pessimistic flow End) Forecast (Bottles) ASSUME THAT THE WEEKLY SHIPMENT DATA (FORECASTING WEEKLY DEMAND) IS INDEPENDENT OF THIS ANALYSIS Chart Area plain your assumptions and methods for making the one forecast Provide any graph in term orect Insert them to the right and forecast values You may do you need asional space What is your imated demand towaru and Pris 30167 dethritis Palanitis a tamil tal Provides the force demand for Spinning world 2 301 14 Global sales of Invest and Pian we provided below through the end of September 2018 Asingle dose of love (bottle) retails, on aver, S1,115 56 per bottle, a single dose of in (hottle) price, on average, at 60 70 per bottle You can assume that this pricing will remain content over the period of the strategic pland theneric competition is present wordwide of Ruly 2013 You may sume that Aurobindo has a slight con orice advantage over Merck for Invent, and that Aurobindones adequate capacity to apply global demand for a new strategic plan is required for 2019-2023, indir forecasts of sales of both products Stede/ining Pro Aseptic/heng manufacturing of steamateformed in that and an injectable producine with me enters the packaging and remain in the the product undy day. About 5 days of action presto fulares en andere produs in the same cittade of production will be out to starache The process activities and better for close botted Wettere shown below The facity can achieve an average throughput of 10 bottles/boardgaver identical twell/finishing the following information has been collected the mere butter at random times over the past year and by meaning ASSUME THAT THE WIKIYOPMENT DATA (FORECASTING WEEKLY DEMAND) IS INDEPENDENT OF THIS ANALYSIS Desain your stutions and who for making the long term forecast Pronde weraphs used in long term forecasting them to the right of your assumption and forcat values. You may add row if you need additional space end Pemand What is your estimated forecasted demand for invane and Primaxin for 2018? Provide the answer in units of BOLES Provide a table of forecasted demand for strategic planning purposes for and Primetin below #1 Pesum LOW Options Pesimit dhe 2019 20 2011 1022 ACTUAL GLOBAL DEMAND SALES Year Global Invanz Sales SUS MM Global Primaxin Sales SUS MM 2010 2011 362 406 610 515 2012 445 384 2013 426 335 2014 488 329 2015 569 2016 561 2017 602 2018 (through end of September 437 Assume that 4th quarter= average of 1st 3 quarters 313 297 280 212 84 85 86 Process & Demand Data 87 88 89 90 Single Process Line Data Average #of Average Activity Process Step Bottles Waiting Time (minutes) Prior to Activity Bottle Staging 168 12.1 Bottle 257 29.08 Tunnel 209 10.9 Sterilization Aseptic Fill 220 Lyophilization 289 13.2 (Freeze-drying) Bottle Capping! 188 91 92 2.1 93 94 0.5 95 96 97 98 Merck & Co., Inc. has developed and currently manufactures tweinyectable and Prima Facerpts from selected Merck Longsoring Primas and invent state "Global sales of land for the treatment of certain infection were 5602 in 2017, one of Noned with 2016, darily by higher sales in the Nether partially offset by lower demands well as higher demand in Brel Worldwide sales of vowe 6 milioni 2016 dece of compared with 2015. Soles performance 2016 United States, largely offset by a dece in Venezue. The potent that provided for printer 2017 and the company antes de sus future periods After patent protection ends for agence ducers will introduce we cost of the product the speed andre of gener entries will end ended the attractiveness of market entry by merk manufacturers, the required and checturing the product. While itti och sextremely difficult to manufacture due to processing complexity and the difficulty le conformance in making roads in Mesother letter Primasin ended in 2008 and generic version entered the global mar 2010 Merck lost patient protection for invang in the US in November 2017 Online 21, 2018 Aurobindo accedere Oversion here for the Aur generic vans in the US at the end of july 2018 Inweis an antibiotic of last resort meaning that it tay only interefter other behave fled the cadence of infections that were to more con de help offset inreds from generic Clinical researchers estimate annual growth in demand for antibiotics such an in the low single data for the foreseeable future due to Demand for at produced by Merck will be dependent in garton Merck's bity to come out wity Performance they to successfully treated winner conformance quality le, meeting manufacturing specifications is an order cualifierConforman ulit nous concern poor quality product reches the market risk and the firm may need to conduct a product recall Product recalls are typically damaging to the stick once in the short term and potentially to the firm's brand the long term become increasingly important as new antibiotics enter the market and due to expected competition from producers of trans Generic ng mature may have introducing new drugs in part because they lack experience with the process. Merck has an advantage over Aurobindo in this respect that because they have length routine process average, at $1.9555 per bottle angle dose of Polisport Global sales of narand Prime we provided below through the end of September 2015. A single down (bottle) is on aver $1,31556 per bottle dose of the bed on average, ut $850.70 per bottle you can assume that this pricing will remain contant over the period of the strategic plan and that geen competition is present worldwide oluly 2013 Aurobindo has a slight cost (price) advantage over Merck for Invant, and that Aurobindo has adequate capacity to wohl demand for Invan. A new strategic plan is required to 2011 dude forecasts of sales of both products Sterile Fillinishing Process Aseptic fishing manufacturing of stene pharmaceutical products performed in a process that is de teren injectable product manner which we that the other it enters the packaging and remains contaminant-free over the life of the product the process is detonin houders/veer About 5 days of production per part failures. Primon and rare produced to the same facility, 9 days of production will be lost to change reacher An $W Calibri 14 -AX Mega - $ 96 9N Condition format Call Format We Style Shes a A- Pessimistic flow End) Forecast (Bottles) ASSUME THAT THE WEEKLY SHIPMENT DATA (FORECASTING WEEKLY DEMAND) IS INDEPENDENT OF THIS ANALYSIS Chart Area plain your assumptions and methods for making the one forecast Provide any graph in term orect Insert them to the right and forecast values You may do you need asional space What is your imated demand towaru and Pris 30167 dethritis Palanitis a tamil tal Provides the force demand for Spinning world 2 301 14 Global sales of Invest and Pian we provided below through the end of September 2018 Asingle dose of love (bottle) retails, on aver, S1,115 56 per bottle, a single dose of in (hottle) price, on average, at 60 70 per bottle You can assume that this pricing will remain content over the period of the strategic pland theneric competition is present wordwide of Ruly 2013 You may sume that Aurobindo has a slight con orice advantage over Merck for Invent, and that Aurobindones adequate capacity to apply global demand for a new strategic plan is required for 2019-2023, indir forecasts of sales of both products Stede/ining Pro Aseptic/heng manufacturing of steamateformed in that and an injectable producine with me enters the packaging and remain in the the product undy day. About 5 days of action presto fulares en andere produs in the same cittade of production will be out to starache The process activities and better for close botted Wettere shown below The facity can achieve an average throughput of 10 bottles/boardgaver identical twell/finishing the following information has been collected the mere butter at random times over the past year and by meaning
